about
Neuroblastoma: molecular pathogenesis and therapy.Molecular profiling of childhood cancer: Biomarkers and novel therapiesThe role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.Novel Platinum(II) compounds modulate insulin-degrading enzyme activity and induce cell death in neuroblastoma cells.Botulinum neurotoxin type C protease induces apoptosis in differentiated human neuroblastoma cells.Norcantharidin Inhibits SK-N-SH Neuroblastoma Cell Growth by Induction of Autophagy and Apoptosis.Novel natural withanolides induce apoptosis and inhibit migration of neuroblastoma cells through down regulation of N-myc and suppression of Akt/mTOR/NF-κB activation.
P2860
Q35564199-E63F9097-C772-4FAF-A749-7F1B83ED34F9Q36250783-7AEB39AE-58EE-4207-8891-0D21A111ED5DQ38175044-A11B2D87-F5B6-41C9-8F68-300E763DF65AQ38934781-170C425F-D7B4-4A5A-A577-5AC57FD8D5ACQ41561905-8B128C37-357B-40E1-8158-62C2781B9833Q42054216-F1F0F102-D9AD-4374-B62A-2C776BFCB758Q51734229-7F546E47-86E2-458B-B87A-C48913C5E1F7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging drugs for neuroblastoma.
@en
type
label
Emerging drugs for neuroblastoma.
@en
prefLabel
Emerging drugs for neuroblastoma.
@en
P2860
P1476
Emerging drugs for neuroblastoma.
@en
P2093
Pablo Berlanga
Vanessa Segura
P2860
P304
P356
10.1517/14728214.2013.796927
P407
P577
2013-05-22T00:00:00Z